ADVFN US – Market Content Editor

  • Immunovant shares climb 7% as fiscal Q3 loss comes in better than expected

    Immunovant shares climb 7% as fiscal Q3 loss comes in better than expected

    Immunovant, Inc. (NASDAQ:IMVT) reported fiscal third-quarter results on Friday that showed a smaller loss than analysts had forecast, lifting investor sentiment toward the clinical-stage immunology company. Shares jumped 7.40% in pre-market trading following the announcement. For the quarter ended December 31, 2025, Immunovant posted a loss of -$0.61 per share, beating consensus expectations of -$0.72…

  • GrafTech shares sink 20% after Q4 results disappoint amid pricing pressure

    GrafTech shares sink 20% after Q4 results disappoint amid pricing pressure

    GrafTech International Ltd. (NYSE:EAF) reported weaker-than-expected fourth-quarter results on Friday, as ongoing pricing pressure across the graphite electrode market continued to weigh on performance. The Ohio-based manufacturer’s shares slumped more than 20.33% in pre-market trading following the release. GrafTech posted a fourth-quarter net loss of $65.1 million, or $2.50 per share, widening from a loss…

  • Cboe tops Q4 forecasts as derivatives activity drives record revenue

    Cboe tops Q4 forecasts as derivatives activity drives record revenue

    Cboe Global Markets (AMEX:CBOE) reported fourth-quarter results on Friday that came in ahead of expectations, supported by strong momentum across its derivatives platform. The exchange operator posted adjusted earnings of $3.06 per share, beating the analyst consensus of $2.85. Revenue reached a record $671.1 million, well above forecasts of $636.57 million. Despite the solid performance,…

  • Hims & Hers slides after FDA signals crackdown on unauthorized copycat medicines

    Hims & Hers slides after FDA signals crackdown on unauthorized copycat medicines

    Shares of Hims & Hers Health (NYSE:HIMS) dropped 10% on Friday after the U.S. Food and Drug Administration warned it would move against companies promoting unapproved versions of prescription drugs, a development that rattled investors just a day after the telehealth group launched a cheaper alternative to a Novo Nordisk (NYSE:NVO) weight-loss treatment. The decline…

  • Plains All American falls short on Q4 earnings, boosts distribution by 10%

    Plains All American falls short on Q4 earnings, boosts distribution by 10%

    Plains All American Pipeline (NASDAQ:PAA) reported fourth-quarter results on Friday that missed market expectations, even as the midstream operator announced a higher cash distribution for unitholders. The company posted adjusted earnings of $0.40 per unit for the quarter, below the analyst consensus of $0.47. Revenue totaled $10.57 billion, also undershooting expectations of $13.42 billion. Following…

  • Johnson Outdoors tops Q1 forecasts as revenue surges 31%

    Johnson Outdoors tops Q1 forecasts as revenue surges 31%

    Johnson Outdoors Inc. (NASDAQ:JOUT) delivered a stronger-than-expected start to its fiscal year, reporting first-quarter results on Friday that beat market forecasts as sales climbed sharply on improved demand and a solid reception for new products. Shares in the outdoor recreation equipment maker rose 1.43% in after-hours trading following the release. For the quarter ended January…

  • Virtus Investment Partners slips after Q4 profit miss offsets revenue surprise

    Virtus Investment Partners slips after Q4 profit miss offsets revenue surprise

    Virtus Investment Partners, Inc. (NYSE:VRTS) shares edged lower on Friday after the asset manager posted fourth-quarter adjusted earnings that came in below expectations, despite delivering stronger-than-forecast revenue. The stock was down 2.86% in pre-market trading following the results. For the quarter ended December 31, 2025, Virtus reported adjusted earnings of $6.50 per share, falling short…

  • AerCap shares slide as cautious 2026 guidance eclipses record 2025 performance

    AerCap shares slide as cautious 2026 guidance eclipses record 2025 performance

    AerCap Holdings N.V. (NYSE:AER) shares fell on Friday after the aircraft leasing group issued a weaker-than-expected outlook for 2026, tempering investor enthusiasm despite a strong fourth quarter and record results for full-year 2025. The world’s largest aircraft lessor saw its stock drop 3.12% in pre-market trading following the announcement. AerCap reported fourth-quarter adjusted earnings of…

  • Dave shares jump as Q4 revenue beats forecasts with 62% surge

    Dave shares jump as Q4 revenue beats forecasts with 62% surge

    Dave Inc. (NASDAQ:DAVE) shares climbed 16% on Friday after the digital banking platform released preliminary fourth-quarter figures showing revenue growth well ahead of market expectations, supported by rapid customer expansion and stronger unit economics. The company reported preliminary Q4 revenue of $164 million, topping the consensus estimate of $153 million and marking a 62% increase…

  • Piper Sandler posts record Q4 revenue, smashes earnings forecasts

    Piper Sandler posts record Q4 revenue, smashes earnings forecasts

    Piper Sandler Companies (NYSE:PIPR) reported a standout fourth quarter for 2025 on Friday, delivering adjusted earnings and revenue that came in well ahead of market expectations and capped a record year for the investment bank. Adjusted earnings reached $6.88 per share for the quarter, comfortably beating analyst estimates of $4.73. Revenue climbed to an all-time…